|
Trusgen’s Practice leaders |
|
R. Bruce Register, Ph.D., — President and CEO |
|
Dr. Register is a multitalented team member and team builder with an extensive science background coupled with intuitive business sense and experience. He is attuned to the global demands and opportunities of the pharmaceutical and biotechnology industries. These attributes and talents have been developed over the course of a 27-year career that covers the spectrum from the laboratory bench top to the executive suite. |
|
Donald F. Gerson, Ph.D. — Biologics and Vaccines |
|
Dr. Gerson has more than 23 years of experience in the pharmaceutical and biotechnology business, with a focus on the establishment, design, construction and operations of large-scale manufacturing facilities in the U.S. and Canada. |
|
Bernd Mechsner, M.S. — Biologics & Engineering |
|
Bernd Mechsner has worked in the engineering, process and business development areas of the biotechnology industry for over 20 years. He has led teams for the design, construction, and operation of biotech facilities in many countries around the globe, with a focus in Asia. |
|
John R. P. Tesser, MD, FACP, FACR — Clinical Development |
|
Dr. Tesser has an extensive history of performing multiple clinical research studies including all forms of rheumatic diseases with an emphasis on rheumatoid arthritis, osteoarthritis, osteoporosis, and pain. He has been the principal investigator on more than 250 clinical research trials. |
